Alkermes Inc. plc

ALKSNASDAQUSD
33.73 USD
0.10 (0.29%)🟢PRE MARKET (AS OF 04:09 AM EDT)
🟢Market: OPEN
Open?$33.72
High?$35.25
Low?$33.72
Prev. Close?$33.73
Volume?111
Avg. Volume?2.5M
VWAP?$33.74
Rel. Volume?0.00x
Bid / Ask
Bid?$33.72 × 200
Ask?$33.74 × 100
Spread?$0.02
Midpoint?$33.73
Valuation & Ratios
Market Cap?5.6B
Shares Out?166.3M
Float?162.4M
Float %?98.4%
P/E Ratio?23.20
P/B Ratio?3.08
EPS?$1.45
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.20Strong
Quick Ratio?1.84Adequate
Cash Ratio?0.72Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
72/100
P/E?
23.2FAIR
P/B?
3.08FAIR
P/S?
3.80FAIR
P/FCF?
11.7CHEAP
EV/EBITDA?
18.6FAIR
EV/Sales?
3.54FAIR
Returns & Efficiency
ROE?
13.3%STRONG
ROA?
9.7%STRONG
Cash Flow & Enterprise
FCF?$480.3M
Enterprise Value?$5.2B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Employees
2.0K
Market Cap
5.5B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1991-07-16
Address
CONNAUGHT HOUSE
DUBLIN 4, L2 00000
Phone: 00-353-1-772-8000